End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion.
Bifulco
Maurizio
M
Pisanti
Simona
S
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors*; D000077285:Rimonabant
D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant